STE vs TSHA · P/E 25, rev $5.46B vs rev $8.3M
STERIS plc (STE) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
STERIS plc (STE) is a medical devices company listed on NYSE.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Latest reported TSHA revenue for 2024-12-31 was $8.3M. Net income was -$89.3M. Revenue was down 46.1% from 2023-12-31 to 2024-12-31. TSHA currently screens at market cap $640.7M.
STE currently screens at market cap $19.43B and trailing P/E 25.1. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the STE and TSHA stock pages for the full models.
Not investment advice.